Skip to content

DR. MORREELS MARC

Active
Private limited company (pre-2019)founded 1990active for 36 yearsPelsstraat(DRL) 12, 3350 Linter, BelgiumKBO/BCE: BE 0440.854.607
Summary

DR. MORREELS MARC has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.3m and a net result of €106,107. Equity has been growing by about 10% per year since 2018. Its solvency ranks better than 77% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 19-05-1990 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.302.614.803 3350 Linter, since 19-05-1990
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Board and ownership

Board
  • MORREELS MarcDirector · since 19-05-1990

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€183,106
▼ 0.9%
Turnover
≈ €340,000
estimated
Profit
€106,107
▼ 13.1%
Equity
€1.3m
▲ 8.6%
Total assets
€1.6m
▲ 11.6%
Score breakdownlowers riskLiquidity: current ratio 6.90, cash €1.1mSector: Human health activities (NACE 86)Equity €1.3m (85.6% of total assets)Size: total assets €1.6mShow the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 60% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 85.6% of total assets
Liquidity 97-2
short-term debt 14.4% · cash 70.8%
Profitability 77-3
return on assets 6.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €120,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.9 (8.26 in 2024), above the usual 1.5. Short-term debt is 14.4% and cash 70.8% of total assets. 14.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 86% on liquidity, 22% on profitability and 50% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 6.90, cash €1.1m
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €1.3m (85.6% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €1.6m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
3 days early
2024
34 days early
2023
36 days early
2022
30 days late
2021
24 days late
2020
20 days late
2019
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 5 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 July (4 of the last 5 accounts filed within 32 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 95% of companies in human healthsector median €124,659 · 20,702 companies €1.3m View
  • Positive: 8 profitable years in a rowprofit 2025: €106,107 8 years View

Recent changes

  1. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as DR. MORREELS MARC: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.1m and €1.5m, founded between 1988 and 1997.

CompanyTotal assetsGross margin
DR. MORREELS MARC Linter€1.6m€0.2m
Dr. Pascal De Smet Aalst€1.4m€0.2m
Dr. M. De Rick - Huisarts Haacht€1.1m€0.2m
Medisch kabinet Dr. Temmerman Tom Berlare€1.5m€0.2m
Dokter De Winter Philippe Diepenbeek€1.4m€0.2m
DR. KAREL PATTYN Oostkamp€1.5m€0.2m
Dokterskabinet Frank De Winter - huisarts Beveren-Kruibeke-Zwijndrecht€1.2m€0.2m
Full comparison

Key facts about DR. MORREELS MARC

What is the company number of DR. MORREELS MARC?
The company number of DR. MORREELS MARC is 0440.854.607. The VAT number is the same number with BE in front: BE 0440.854.607.
Where is DR. MORREELS MARC based?
The registered office is at Pelsstraat(DRL) 12, 3350 Linter.Company details
What does DR. MORREELS MARC do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. MORREELS MARC?
The legal form of DR. MORREELS MARC is Private limited company (pre-2019) (BVBA).
When was DR. MORREELS MARC founded?
DR. MORREELS MARC was founded on 19-05-1990.
Is DR. MORREELS MARC still active?
Yes, DR. MORREELS MARC is an active enterprise in the KBO register.
What is the turnover of DR. MORREELS MARC?
The turnover in financial year 2025 is ≈ €340,000. This figure is estimated from the gross margin of €183,106 and 30 comparable companies (NACE 86210). It probably lies between €270,000 and €410,000.Financials
Is DR. MORREELS MARC profitable?
In financial year 2025, DR. MORREELS MARC made a profit of €106,107.
Where can I find the annual accounts of DR. MORREELS MARC?
DR. MORREELS MARC filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. MORREELS MARC due?
DR. MORREELS MARC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.